[18F]PSMA-1007
Sponsors
Ospedale San Raffaele S.r.l., Irene Burger, ABX advanced biochemical compounds GmbH, Insel Gruppe AG, University Hospital Bern
Conditions
Patients with clinical suspicion of clinically relevant prostate cancerProstate CancerProstate Cancer Recurrent
Phase 2
Phase 3
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
CompletedNCT04742361
Start: 2021-08-27End: 2025-05-05Updated: 2025-07-15
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
RecruitingNCT06122584
Start: 2024-06-13End: 2027-09-01Target: 380Updated: 2026-04-14
Unknown Phase
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA
CompletedNCT03187990
Start: 2017-03-03End: 2021-08-03Updated: 2021-09-02
Diagnostic Accuracy and Performance of 18F-PSMA-1007
CompletedNCT04986280
Start: 2021-07-13End: 2024-03-30Updated: 2024-06-07